Brief: Pharvaris Reports First Quarter 2025 Financial Results and Provides Business Update
13/05/2025 21:38
May 13 (Reuters) - Pharvaris NV PHVS.O: PHARVARIS N.V. Q1 EPS EUR -0.85 VERSUS. IBES ESTIMATE EUR -0.76 Source text: ID:nGNX4ryTzj Further company coverage: PHVS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharvaris
See all newsU.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
U.S. STOCKS ON THE MOVE-Qualcomm, Eaton, Howmet Aerospace
Pharvaris' genetic disorder drug meets main goal in late-stage trial (updated)
U.S. STOCKS ON THE MOVE-Sigma Lithium, Shake Shack, Novartis
Pharvaris gains after genetic disorder drug meets late-stage trial goal